Market open
$
4.64
Change
+0.12 +2.77%
Volume
Volume 124,589
Feb 6, 2023, 11:48 a.m.
Real time quotes
Previous close
$ 4.51
$ 4.64
Change
+0.12 +2.77%
Day low
Day high
$4.49
$4.64

52 week low
52 week high
$4.18
$9.79

Market cap
$375.63M
Average volume
431,523
P/E ratio
12.61
Rev. per Employee
$3.26M
EPS
0.37
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on AVIR
-
Biotech Stocks Are Still Falling. The Near-Term Outlook Is Grim.
- Barron's Online
-
8 Biotechs So Cheap Their Technology Is Effectively Free
- Barron's Online
-
Here Are 8 Biotech Stocks That Trade for Less Than Their Cash
- Barron's Online
-
Pfizer's Covid Antiviral Shows Stunning Efficacy
- Barron's Online
-
Atea Pharmaceuticals stock price target cut to $16 from $61 at J.P. Morgan
- Tomi Kilgore
-
Atea Pharmaceuticals downgraded to neutral from overweight at J.P. Morgan
- Tomi Kilgore
-
Why Facebook May Be Changing Its Name
- Barron's Online
-
Stocks Closed Up Today. Profits Are a Beautiful Thing.
- Barron's Online
-
Don't Count Out Covid-19 Monoclonal Antibody Treatments
- Barron's Online
-
FDA Will Consider Regeneron's Covid-19 Antibody for Full Approval
- Barron's Online
-
Merck Submits Covid Pill to FDA for Emergency Approval
- Barron's Online
-
Dice Therapeutics and Hemisphere Media See Activist Action
- Barron's Online
-
Merck Says Pill Cuts Covid Hospitalization by 50%
- Barron's Online
-
Merck: Covid-19 Pill Looks Good Against Variants
- Barron's Online
- Loading more headlines...
Other News on AVIR
-
10-Q: ATEA PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Atea wins FDA Fast Track status for dengue treatment
- Seeking Alpha
-
AJU IB Investment Co., Ltd. Buys 3, Sells 2 in 2nd Quarter
- GuruFocus.com
- Loading more headlines...
Press Releases on AVIR
-
Atea Pharmaceuticals Highlights Strategic Priorities for 2023
- GlobeNewswire
-
Atea Pharmaceuticals Announces Upcoming Investor Events
- GlobeNewswire
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com